Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Zonagen reports Androxal phase I/II study results

July 19, 2004

Atorvastatin improves erectile function in men with hypercholesterolemia-related ED

July 19, 2004

European marketing authorization for Vesicare for overactive bladder

July 12, 2004

Aminoalcohol derivatives for the treatment of urinary incontinence

July 9, 2004

NexMed and Schering AG sign Alprox-TD agreement

July 8, 2004

BioXell acquires from Roche rights to new indications for BXL-628

July 6, 2004

Vasopressin V2 receptor antagonist effective aquaretic in vivo

July 2, 2004

NX-1207 shows potential as a front-line treatment for BPH in phase I/II trials

July 2, 2004

The efficacy of vardenafil in ED is not affected by glycemic control or diabetes

July 1, 2004

Theravance presents new muscarinic M2 antagonists with utility in overactive bladder

June 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...